• [1]
    Simon, G.L., Gorbach, S.L. (1986) The human intestinal microflora. Dig. Dis. Sci. 31, 47S62S.
  • [2]
    Misuoka, T. (1980) A Color Atlas of Anaerobic Bacteria. 341, Sobunsya, Tokyo.
  • [3]
    Roberfroid, M.B., Bornet, C., Cummings, J.H. (1995) Colonic microflora: Nutrition and health. Nutr. Rev. 53, 127130.
  • [4]
    Salminen, S., Bouley, C., Boutron-Ruault, M.C., Cummings, J.H., Franck, A., Gibson, G.R., Isolauri, E., Moreau, M.C., Roberfroid, M., Rowland, I. (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80, S147S171.
  • [5]
    Salminen, S., Isolauri, E., Salminen, E. (1996) Clinical use of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 70, 347358.
  • [6]
    Salminen, S., Laine, M., von Wright, A., Vuopio-Varkila, J., Korhonen, T., Mattila-Sandholm, T. (1996) Development of selection criteria for probiotic strains to assess their potential in functional foods: A Nordic and European approach. Biosci. Microflora 2, 2328.
  • [7]
    Salminen, S., Ouwehand, A., Benno, Y., Lee, Y.K. (1999) Probiotics: how should they be defined. Trends Food Sci. Technol. 10, 107110.
  • [8]
    Ouwehand, A.C., Salminen, S. (1999) The health effects of viable and non-viable cultured milk. Int. Dairy J. 8, 749758.
  • [9]
    Famularo, G., Moretti, S., Marcellini, S. and Simone, C.D. (1997) Stimulation of immunity by probiotics. In: Probiotics 2: Applications and Practical Aspects, ad. R Fuller, Chapman and Hall.
  • [10]
    Saxelin, M., Salminen, S. and Isolauri, E. (1998) Clinical efficacy of a human Lactobacillus strain as a probiotic in functional foods. In: The Consumer, the Products and the Evidence (Sadler, M.J. and Saltmarsh, M., Eds.), The Royal Soc. Chem. Cambridge.
  • [11]
    Chauvieire, G., Coconnier, M.H., Kerneis, S., Fourniat, J., Servin, A.L. (1992) Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. J. Gen. Microbiol. 138, 16891696.
  • [12]
    Kirjavainen, P.V., Ouwehand, A.C., Isolauri, E., Salminen, S. (1998) The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol. Lett. 167, 185189.
  • [13]
    Tuomola, E.M., Salminen, S. (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol. 41, 4551.
  • [14]
    Saxelin, M. (1996) Colonization of the human gastrointestinal tract by probiotic bacteria. Nutr. Today 31 (Suppl. 1), 5s8s.
  • [15]
    Benno, Y., He, F., Hosoda, M., Hashimoto, H., Kojima, T., Yamazaki, K., Iino, H., Mykkanen, H., Salminen, S. (1996) Effects of Lactobacillus GG yoghurt on human intestinal microecology in Japanese subjects. Nutr. Today 31 (Suppl. 1), 9s11s.
  • [16]
    Oksanen, P., Salminen, S., Saxelin, M., Hamalainen, P., Ihantola-Vormisto, A., Muurasniemi-Isoviita, L., Nikkari, S., Oksanen, T., Porsti, I., Salminen, E., Sittonen, S., Stuckey, H., Toppila, A., Vapaatalo, H. (1990) Prevention of traveller's diarrhoea by Lactobacillus GG. Ann. Med. 22, 5365.
  • [17]
    Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P., Koivula, T. (1991) A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhoea in children. Pediatrics 88, 9097.
  • [18]
    Kaila, M., Isolauri, E., Soppi, E., Virtanen, E., Laine, S., Arvilommi, H. (1992) Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 32, 141144.
  • [19]
    Kaila, M., Isolauri, E., Saxelin, M., Arvilommi, H., Vesikari, T. (1995) Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Child. 72, 5153.
  • [20]
    Majamaa, H., Isolauri, E. (1997) Probiotics: A novel approach in the management of food allergy. J. Allergy Clin. Immnol. 99, 179185.
  • [21]
    Pelto, L., Isolauri, E., Lilius, E.M., Nuutila, J., Salminen, S. (1998) Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have immunostimulatory effect in health subjects. Clin. Exp. Allergy 28, 14741479.
  • [22]
    Kitazawa, H., Yamaguchi, T., Miura, M., Saito, T., Itoh, T. (1993) B-cell mitogen produced by slime-forming encapsulated Lactococcus lactis ssp. cremoris isolated from ropy sour milk, Viili. J. Dairy Sci. 76, 15141519.
  • [23]
    Schiffrin, E.J., Rochat, F., Link-Amster, H., Aeschlimann, J.M., Donnet-Hughes, A. (1994) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78, 491497.
  • [24]
    Link-Amster, H., Rochat, F., Saudan, K.Y., Mignot, O., Aeschlimann, J.M. (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10, 5564.
  • [25]
    Isolauri, E., Pelto, L., Nuutila, J., Majamaa, H., Lilius, E.M., Salminen, S. (1997) Altered expression of IgG and complement receptors indicates a significant role of phagocytes in atopic dermatitis. J. Allergy Clin. Immunol. 99, 707713.
  • [26]
    Malin, M., Suomalainen, H., Saxelin, M., Isolauri, E. (1996) Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann. Nutr. Med. 40, 137145.
  • [27]
    Isolauri, E., Majamaa, H., Arvola, T., Rantala, I., Virtanen, F., Arvilommi, H. (1993) Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 105, 16431650.
  • [28]
    Sütas, Y., Soppi, E., Korhonen, H., Syväoja, E.L., Saxelin, M., Rokka, T., Isolauri, E. (1996) Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. J. Allergy Clin. Immunol. 98, 216224.
  • [29]
    Sütas, Y., Hurme, H., Isolauri, E. (1996) Downregulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolyzed with Lactobacillus GG derived enzymes. Scand. J. Immunol. 43, 687689.
  • [30]
    Ellonz, F., Adam, A., Ciorbarn, R., Lederer, E. (1974) Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59, 13171325.